Azaxanthene based selective glucocorticoid receptor modulators: Design, synthesis, and pharmacological evaluation of (S)-4-(5-(1-((1,3,4-Thiadiazol-2- yl)amino)-2-methyl-1-oxopropan-2-yl)-5 H-chromeno[2,3-b]pyridin-2-yl)-2-fluoro- N, N-dimethylbenzamide (BMS-776532) and its methylene homologue (BMS-791826)
David S. Weinstein, Hua Gong, Arthur M. Doweyko, Mark Cunningham, Sium Habte, Jin Hong Wang, Deborah A. Holloway, Christine Burke, Ling Gao, Victor Guarino, Julie Carman, John E. Somerville, David Shuster, Luisa Salter-Cid, John H. Dodd, Steven G. Nadler, Joel C. Barrish
Dive into the research topics of 'Azaxanthene based selective glucocorticoid receptor modulators: Design, synthesis, and pharmacological evaluation of (S)-4-(5-(1-((1,3,4-Thiadiazol-2- yl)amino)-2-methyl-1-oxopropan-2-yl)-5 H-chromeno[2,3-b]pyridin-2-yl)-2-fluoro- N, N-dimethylbenzamide (BMS-776532) and its methylene homologue (BMS-791826)'. Together they form a unique fingerprint.